Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 06, 2020, titled "Glenmark introduces higher strength (400 mg) of FabiFlu�� to reduce pill burden of COVID-19 treatment".
Press Release Aug 06 2020
Filed with NSE ·
6ix hasn’t read this filing yet.
Glenmark Pharmaceuticals Limited on 6ix
Later from Glenmark Pharmaceuticals
- Press Release Oct 07 2020
- Press Release Oct 09 2020
- Press Release Oct 14 2020
- Press Release Oct 19 2020
- Press Release Nov 11 2020
Follow Glenmark Pharmaceuticals into a list and get an email when it puts out news.
Follow Glenmark Pharmaceuticals